Evidence map›Paper›PMID 42438569›Full record

ReviewThe Lancet regional health. Western Pacific2026

HPV vaccination policies and implementation for adolescents in low- and middle-income countries: a scoping review.

Shudan Liu, Di Wu, Siyan Ye, Yuqing Xiao, Meng Wu, Shu Chen, Xinyu Zhang, Lei Guo, Qin Zhang, Yang Zhou and 12 more

Erratum issuedAbstract readReview
In one paragraph

Review in The Lancet regional health. Western Pacific, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Shudan LiuResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Di WuSchool of Nursing, Chongqing Medical University, Chongqing, China.
Siyan YeResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Yuqing XiaoResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Meng WuResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Shu ChenNational Centre for Immunisation Research and Surveillance, New South Wales, Australia.
Xinyu ZhangGlobal Health Research Center, Duke Kunshan University, Kunshan, Jiangsu, China.
Lei GuoGlobal Health Research Center, Duke Kunshan University, Kunshan, Jiangsu, China.
Qin ZhangResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Yang ZhouResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Xiangju WuResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Qian YangResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Rongchang XiaoResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Jie ZhangResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Xinyi FengResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Jinghan WangResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Xianwen ShiResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Xiaoyuan ZhangResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.
Jiawei XuChongqing Center for Disease Control and Prevention (Chongqing Academy of Preventive Medicine), Chongqing, China.
Jianchao ShaoImmunization Program Management Department, Chongqing Shapingba District Center for Disease Control and Prevention, Chongqing, China.
Shenglan TangDuke Global Health Institute, Duke University, NC, USA.
Qin LiuResearch Center for Environment and Human Health, Research Center for Medicine and Social Development, School of Public Health, Chongqing Medical University, Chongqing, China.

Funding

Bill & Melinda Gates Foundation INV-034554
6 · The paper itself

Abstract

This scoping review mapped adolescent HPV vaccination policies across 84 low- and middle-income countries (LMICs) with national HPV immunization programs and synthesized implementation evidence through July 2025. Focusing on adolescents aged 9-14 years, we identified policy convergence in target age, school-based delivery, and free vaccination provision, alongside divergence in gender eligibility, vaccine type, and funding mechanisms across income levels. Nearly half of LMICs have adopted single-dose schedules, reflecting a clear trend toward dosing simplification. Despite these policy advances, only 9.8% of countries achieved the WHO 90% complete vaccination target among females by age 15. Coverage analysis suggested that school-based programs maintained more stable performance over time than health facility-based approaches. Implementation evidence identified four facilitating factors, while barriers varied by income level. School-based programs complemented by mixed delivery approaches and single-dose schedules may offer a promising pathway toward the 2030 cervical cancer elimination goals.

Indexed as

AdolescentsHPV vaccinationImplementationLow- and middle-income countries (LMICs)Scoping reviewVaccination policies

Identifiers

PMID42438569
PMCPMC13356746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.